OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The crucial role of early-life gut microbiota in the development of type 1 diabetes
He Zhou, Lin Sun, Siwen Zhang, et al.
Acta Diabetologica (2020) Vol. 58, Iss. 3, pp. 249-265
Closed Access | Times Cited: 24

Showing 24 citing articles:

The Role of the Gut Microbiota in the Pathogenesis of Diabetes
Weronika Bielka, Agnieszka Przezak, Andrzej Pawlik
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 480-480
Open Access | Times Cited: 106

Role of gut microbiota in the pathogenesis and treatment of diabetes mullites: Advanced research-based review
Junjun Ye, Zezhen Wu, Yifei Zhao, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 30

Can the Evidence-Based Use of Probiotics (Notably Saccharomyces boulardii CNCM I-745 and Lactobacillus rhamnosus GG) Mitigate the Clinical Effects of Antibiotic-Associated Dysbiosis?
Dan Linetzky Waitzberg, Francisco Guarner, Iva Hojsak, et al.
Advances in Therapy (2024) Vol. 41, Iss. 3, pp. 901-914
Open Access | Times Cited: 5

Mutual modulation of gut microbiota and the immune system in type 1 diabetes models
Estela Rosell‐Mases, Alba Santiago, Marta Corral-Pujol, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 10

Risk Factors of Type 1 Diabetes Mellitus

Biomedical Science and Clinical Research (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 10

Deciphering the interdependent labyrinth between gut microbiota and the immune system
Amandeep Saini, Priyanka Dalal, Deepika Sharma
Letters in Applied Microbiology (2022) Vol. 75, Iss. 5, pp. 1122-1135
Open Access | Times Cited: 10

Calcium-Sensitive Receptors Alters Intestinal Microbiota Metabolites Especially SCFAs and Ameliorates Intestinal Barrier Damage in Neonatal Rat Endotoxemia
Yan Sun, Jiayu Song, Lan Xue, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 5707-5717
Open Access | Times Cited: 4

Clinical Outcomes of Fetal Stem Cell Transplantation in Type 1 Diabetes Are Related to Alternations to Different Lymphocyte Populations
Ali Tootee, Behrouz Nikbin, Ensieh Nasli‐Esfahani, et al.
Medical Journal of the Islamic Republic of Iran (2022)
Open Access | Times Cited: 3

The Microbiome and Diabetes
Amanda J. Cox, Nicholas P. West, Allan W. Cripps
(2024), pp. 261-271
Closed Access

Diabetes Mellitus
Myron Yanoff, Joseph W. Sassani
Elsevier eBooks (2024), pp. 643-679.e10
Closed Access

Peranan Mikrobiota Usus Manusia Golongan Bakteri Asam Laktat Sebagai Sumber Produksi Potensial dalam Manajemen Terapi Diabetes Melitus Tipe 1 pada Anak
Nindy Putri Amalia, Bima Diokta Alparisi, Riski Dimas, et al.
SCRIPTA SCORE Scientific Medical Journal (2024) Vol. 6, Iss. 1, pp. 67-75
Open Access

Unravelling the Role of Gut and Oral Microbiota in the Pediatric Population with Type 1 Diabetes Mellitus
Stefania Luppi, Luana Aldegheri, Eros Azzalini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10611-10611
Open Access

Gut Microbiota Mechanism of Fetal-Originated Disease
Hui Wang, Xiaoqian Lu, Chi Ma
(2024), pp. 83-95
Closed Access

Antibiotic-associated dysbiosis: modern strategy for microbiota restoration. A review
Elina S. Dzottsoeva, А.В. Горелов, Ludmila R. Khabibulina
Pediatrics Consilium Medicum (2024), Iss. 4, pp. 386-395
Closed Access

Immunopathology of Type 1 Diabetes and Immunomodulatory Effects of Stem Cells: A Narrative Review of the Literature
Ali Tootee, Behrouz Nikbin, Aziz Ghahary, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2021) Vol. 22, Iss. 2, pp. 169-197
Closed Access | Times Cited: 2

Mutual Modulation of Gut Microbiota and the Immune System in Type 1 Diabetes Models
Estela Rosell‐Mases, Alba Santiago, Marta Corral-Pujol, et al.
Research Square (Research Square) (2023)
Open Access

Novel Therapeutic Strategies Targeting Gut Microbiota to Treat Diseases
Shaimaa H. Negm
(2023), pp. 133-141
Closed Access

Neonatal Microbiome: Is it Still Beneficial?
Mohamed Shawky Elfarargy, Dalia hamdy Elbadry, Ahmad Roshdy Ahmad, et al.
Endocrine Metabolic & Immune Disorders - Drug Targets (2023) Vol. 24, Iss. 6, pp. 617-625
Closed Access

Triggering Role of Viruses and Bacteria in Type I Diabetes
Hatice Gümüş
(2023), pp. 141-150
Closed Access

The types of delivery and components of metabolic syndrome among patients with schizophrenia without therapy
Sergej Nadalin, Alena Buretić‐Tomljanović, Lena Zatković, et al.
Medicina Fluminensis (2021) Vol. 57, Iss. 4, pp. 437-443
Open Access

Page 1

Scroll to top